Welcome to our dedicated page for Acme United SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind every bandage kit and Westcott scissor Acme United ships each quarter? Our dedicated ACU SEC filings hub puts the company’s diverse first-aid and cutting-tool businesses in context. Whether you need the inventory turns hidden in an Acme United quarterly earnings report 10-Q filing or revenue splits buried deep in the annual 10-K, the documents sit here the moment they hit EDGAR—and our AI is already reading them.
Stock Titan’s engine converts dense disclosures into plain-language briefs, so understanding Acme United SEC documents with AI becomes routine. Want a heads-up on executive moves? Receive Acme United Form 4 insider transactions real-time alerts and review historical Acme United insider trading Form 4 transactions in seconds. Unsure which form answers which question? Our guided view links each topic—raw-material costs, OSHA compliance, seasonality of school demand—to the exact line item in the filing.
Investors typically use this page to:
- Compare margin trends across first aid, cutting, and safety segments with our Acme United earnings report filing analysis.
- Track Acme United executive stock transactions Form 4 before material announcements.
- Read the Acme United proxy statement executive compensation to gauge incentive alignment.
- Decode an unexpected recall through an Acme United 8-K material events explained summary.
- Explore an Acme United annual report 10-K simplified walkthrough for long-term outlook.
Every filing type—10-K, 10-Q, 8-K, S-3, DEF 14A, and more—is organized chronologically and cross-referenced, turning hours of document hunting into minutes of insight.
Rex Lynn Davidson, a director of Acme United Corp (ACU), reported exercising employee stock options on 08/12/2025 to acquire 2,500 shares of common stock at a price of $43.40 per share. Following the exercise, Davidson directly beneficially owned 29,000 shares. The Form 4 was signed on 08/14/2025. The filing shows a routine option exercise by an insider and records the updated direct ownership.
On August 12-13, 2025, Richmond Y. Holden Jr., a director of Acme United Corp (ACU), exercised employee stock options and completed related transactions. He exercised 2,500 options with a $43.40 exercise price (exercisable and executed 08/12/2025) producing 2,500 underlying shares, and exercised 2,500 options with a $22.60 exercise price (executed 08/13/2025) producing 2,500 underlying shares. Concurrently, 2,500 shares were acquired at $22.66 and 2,500 shares were disposed of via a net cash settlement at an effective price of $44.58, reflecting an exercise settled without issuing shares. Following these transactions, Mr. Holden beneficially owned 21,500 shares from derivative holdings and 15,250 shares direct after the net settlement, per the reporting table.
Brian Barker, a director of Acme United Corp (ACU), reported a derivative-to-equity transaction on 08/12/2025. The filing shows the exercise/acquisition of 2,500 shares underlying an employee stock option with an indicated price of $43.4 per share. After the reported transaction, Mr. Barker beneficially owned 19,000 shares. The Form 4 is signed by Brian Barker on 08/14/2025 and identifies his address in Shelton, CT.
Paul J. Conway, a director of Acme United Corp (ACU), reported a securities transaction on Form 4. The filing shows an employee stock option exercise on 08/12/2025 that acquired 2,500 shares of Common Stock at a conversion/exercise price of $43.4 per share. Following the reported transaction, Mr. Conway beneficially owns 7,500 shares. The Form 4 is signed and dated 08/14/2025 and lists Mr. Conway's address in Shelton, CT. No additional derivatives, dispositions, or indirect ownership details are included in the filing.
Susan H. Murphy, a director of Acme United Corp (ACU), exercised an employee stock option on 08/12/2025 to acquire 2,500 shares at an exercise price of $43.40 per share. The options became exercisable on 08/13/2025 and expire 08/12/2035. Following the transaction, Ms. Murphy beneficially owns 29,000 shares on a direct basis. The Form 4 was signed 08/14/2025 and reports the change required under Section 16.
ACU Q2-25 10-Q highlights:
- Revenue: Q2 net sales $54.0 M, -3% YoY; 6-mo $100.0 M, flat YoY.
- Profitability: Q2 gross margin 41.0% (40.8% LY); operating income $6.4 M (flat); net income $4.8 M, +7% YoY; diluted EPS $1.16 vs $1.09. 6-mo net income $6.4 M, +5%; diluted EPS $1.57 vs $1.47.
- Segment trends: U.S. sales -5% on tariff-driven back-to-school order cancellations; Canada +28% on first-aid demand; Europe -3% (shipment delays).
- Cash & liquidity: Operating cash inflow $3.0 M vs $-3.3 M LY; capex $3.0 M. Cash $3.6 M; revolver borrowings $16.4 M (-$1.3 M YTD); mortgage $10.2 M; long-term-debt-to-equity 22.9%.
- Balance sheet: Working capital $77.9 M; current ratio 4.3x. Inventory $57.3 M, turnover unchanged at 2.1x.
- Credit facility: $65 M HSBC revolver maturity extended to 5/31/27 at SOFR +1.75%.
- Controls: Material weakness in IT general controls persists; remediation expected by YE-25.
- Outlook drivers: tariff volatility, supply-chain diversification, demand seasonality (back-to-school), ongoing integration of Elite First Aid (no new financial impact disclosed).
FAQ
What is the current stock price of Acme United (ACU)?
What is the market cap of Acme United (ACU)?
